BEIJING, China, September 11, 2026 — GL Capital, a leading China-focused professional healthcare investment firm, today announced that it has brought Novo Holdings, a leading global healthcare and life sciences investment firm, in as a minority strategic investor in its portfolio company Huizhou Fo...

GL Capital, a leading private equity firm focusing on healthcare investment in China, has spearheaded Chinese healthcare companies' foray into Southeast Asia, conducting a week-long Southeast Asia-China Healthcare Summit and business exploration from September 5th to 10th. The event wa...

A consortium led by GL Capital Group ("GL Capital”), a leading healthcare-focused private equity firm, has made a significant minority investment in Sangon Biotech (Shanghai) Co., Ltd ("Sangon Biotech" or "Sangon" or "the Company"). Founded in 1995, Sangon Biotech...

GL Capital Group (“GL Capital”), a leading healthcare-focused private equity firm, and Huizhou Foryou Medical Devices Co., Ltd (“Foryou Medical” or “the Company”) have signed an agreement for a GL Capital-led consortium to acquire a majority stake in Foryou Medical. Founded in 2005, Foryou Med...